Article
Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come
1 Nov 2011
Abstract excerpt
Molecular chaperone-peptide complexes extracted from tumors (heat shock protein [HSP] vaccines) have been intensively studied in the preceding two decades, proving to be safe and effective in treating a number of malignant diseases. They offer personalized therapy and target a cross-section of antigens expressed in patients' tumors. Future advances may rely on understanding the molecular underpinnings of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
